Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Change in Accured Expenses (2019 - 2025)

Summit Therapeutics' Change in Accured Expenses history spans 7 years, with the latest figure at $12.8 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 36.65% year-over-year to $12.8 million; the TTM value through Dec 2025 reached $12.9 million, up 8.85%, while the annual FY2025 figure was $12.9 million, 8.85% up from the prior year.
  • Change in Accured Expenses reached $12.8 million in Q4 2025 per SMMT's latest filing, up from $5.5 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $12.8 million in Q4 2025 to a low of -$8.3 million in Q2 2023.
  • Average Change in Accured Expenses over 5 years is $1.5 million, with a median of $1.2 million recorded in 2023.
  • Peak YoY movement for Change in Accured Expenses: surged 1721.83% in 2021, then crashed 3256.91% in 2023.
  • A 5-year view of Change in Accured Expenses shows it stood at $2.1 million in 2021, then soared by 96.79% to $4.0 million in 2022, then soared by 85.2% to $7.5 million in 2023, then increased by 24.97% to $9.4 million in 2024, then skyrocketed by 36.65% to $12.8 million in 2025.
  • Per Business Quant, the three most recent readings for SMMT's Change in Accured Expenses are $12.8 million (Q4 2025), $5.5 million (Q3 2025), and -$7.0 million (Q2 2025).